The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients

CONCLUSION: PIVKA-II is superior to AFP in HCC screening, and AFP in combination with PIVKA-II significantly improves the diagnostic value for Chinese HCC patients. PIVKA-II could effectively indicate HCC accompanied by PVTT and help to optimize the therapeutic strategy.PMID:33628341 | PMC:PMC7884179 | DOI:10.1155/2021/8868370

Source: Disease Markers - February 25, 2021 Category: Laboratory Medicine Authors: Fei Xu Lulu Zhang Wenting He Di Song Xiaomeng Ji Jianyong Shao Source Type: research